BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Fibrosis
1
Obeticholic acid attenuates human immunodeficiency virus/alcohol metabolism-induced pro-fibrotic activation in liver cells
11/24/2020 12:41:21 PM | Browse: 39 | Download: 43
2
Efficacy and safety of anti-hepatic fibrosis drugs
11/6/2020 7:36:12 AM | Browse: 56 | Download: 112
3
Advances in the treatment of nonalcoholic steatohepatitis
10/29/2020 5:34:30 AM | Browse: 94 | Download: 102
4
Periportal thickening on magnetic resonance imaging for hepatic fibrosis in infantile cholestasis
6/6/2020 2:43:56 PM | Browse: 172 | Download: 219
5
Macrophages in metabolic associated fatty liver disease
4/28/2020 8:04:30 AM | Browse: 156 | Download: 158
6
Fibroblast growth factor signaling in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Paving the way to hepatocellular carcinoma
1/16/2020 7:58:40 AM | Browse: 194 | Download: 312
7
Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C
1/13/2020 11:27:12 AM | Browse: 227 | Download: 295
8
Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source
9/7/2019 4:43:36 AM | Browse: 280 | Download: 395
9
Layered enhancement at magnetic resonance enterography in inflammatory bowel disease: A meta-analysis
8/21/2019 9:19:18 AM | Browse: 282 | Download: 413
10
Role of sodium-glucose co-transporter-2 inhibitors in the management of nonalcoholic fatty liver disease
7/28/2019 10:51:57 AM | Browse: 250 | Download: 164
11
Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets
7/6/2019 6:23:58 AM | Browse: 284 | Download: 385
12
Roles of hepatic stellate cells in acute liver failure: From the perspective of inflammation and fibrosis
5/27/2019 8:24:36 AM | Browse: 276 | Download: 315
13
Effectiveness of venous thromboembolism prophylaxis in patients with liver disease
4/26/2019 3:40:00 AM | Browse: 311 | Download: 259
14
Repurposing drugs to target nonalcoholic steatohepatitis
4/18/2019 5:48:09 AM | Browse: 367 | Download: 306
15
Persistent elevation of fibrosis biomarker cartilage oligomeric matrix protein following hepatitis C virus eradication
3/27/2019 10:37:20 AM | Browse: 349 | Download: 322
16
Diffusion-weighted magnetic resonance imaging and micro-RNA in the diagnosis of hepatic fibrosis in chronic hepatitis C virus
3/20/2019 5:32:10 AM | Browse: 422 | Download: 475
17
Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice
3/20/2019 5:32:10 AM | Browse: 358 | Download: 294
18
Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects
2/26/2019 11:29:04 AM | Browse: 420 | Download: 345
19
Human immunodeficiency virus and hepatotropic viruses co-morbidities as the inducers of liver injury progression
1/26/2019 11:40:14 AM | Browse: 415 | Download: 364
20
Correlation analysis of collagen proportionate area in Budd-Chiari syndrome: A preliminary clinicopathological study
1/26/2019 8:24:19 AM | Browse: 277 | Download: 257
21
Current status, problems, and perspectives of non-alcoholic fatty liver disease research
1/14/2019 2:54:12 PM | Browse: 492 | Download: 379
22
Role of cenicriviroc in the management of nonalcoholic fatty liver disease
12/27/2018 8:56:32 AM | Browse: 292 | Download: 214
23
Management of local recurrence after endoscopic resection of neoplastic colonic polyps
12/21/2018 6:09:14 AM | Browse: 358 | Download: 394
24
Liver as a target of human immunodeficiency virus infection
11/13/2018 8:04:45 AM | Browse: 437 | Download: 355
25
Carcinogenesis on the background of liver fibrosis: Implications for the management of hepatocellular cancer
10/18/2018 10:13:24 AM | Browse: 349 | Download: 356
26
A small molecule fibrokinase inhibitor in a model of fibropolycystic hepatorenal disease
9/7/2018 9:21:44 AM | Browse: 412 | Download: 411
27
Polycystic kidney and hepatic disease 1 gene mutations in von Meyenburg complexes: Case report
9/7/2018 1:56:18 AM | Browse: 332 | Download: 271
28
Liver intravoxel incoherent motion diffusion-weighted imaging for the assessment of hepatic steatosis and fibrosis in children
7/19/2018 7:04:34 AM | Browse: 461 | Download: 454
29
Responsibility of hepatitis C virus in the development of hepatocellular carcinoma: From molecular alterations to possible solutions
6/28/2018 2:47:35 AM | Browse: 519 | Download: 383
30
Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction
4/27/2018 3:25:40 AM | Browse: 538 | Download: 290
31
Beneficial effects of naringenin in liver diseases: Molecular mechanisms
4/27/2018 3:25:40 AM | Browse: 535 | Download: 355
32
Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity
4/19/2018 7:56:07 AM | Browse: 486 | Download: 350
33
Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals
3/16/2018 12:27:25 PM | Browse: 543 | Download: 406
34
Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease
3/16/2018 12:27:25 PM | Browse: 493 | Download: 308
35
Collagen proportionate area correlates to hepatic venous pressure gradient in non-abstinent cirrhotic patients with alcoholic liver disease
1/26/2018 8:09:36 AM | Browse: 492 | Download: 307
36
Role of inflammatory response in liver diseases: Therapeutic strategies
1/26/2018 8:09:36 AM | Browse: 625 | Download: 444
37
Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis
1/14/2018 5:07:58 AM | Browse: 613 | Download: 313
38
Antifibrogenic effects of vitamin D derivatives on mouse pancreatic stellate cells
1/14/2018 5:07:58 AM | Browse: 503 | Download: 295
39
Molecular basis of hepatocellular carcinoma induced by hepatitis C virus infection
12/27/2017 10:31:19 AM | Browse: 540 | Download: 406
40
Clinical epidemiology and disease burden of nonalcoholic fatty liver disease
12/20/2017 2:49:19 AM | Browse: 552 | Download: 375
41
Pathological process of liver sinusoidal endothelial cells in liver diseases
11/20/2017 4:03:35 AM | Browse: 618 | Download: 314
42
Risk of liver disease in methotrexate treated patients
9/15/2017 5:43:48 AM | Browse: 547 | Download: 450
43
Expression of matrix metalloproteinase-11 is increased under conditions of insulin resistance
9/13/2017 7:36:12 AM | Browse: 480 | Download: 509
44
CD4+ T cells and natural killer cells: Biomarkers for hepatic fibrosis in human immunodeficiency virus/hepatitis C virus-coinfected patients
9/7/2017 2:39:18 AM | Browse: 502 | Download: 586
45
Fibrinogen deficiency suppresses the development of early and delayed radiation enteropathy
7/12/2017 6:45:23 AM | Browse: 498 | Download: 506
46
Impact of hepatitis C oral therapy in portal hypertension
7/12/2017 6:45:23 AM | Browse: 552 | Download: 798
47
Naringenin prevents experimental liver fibrosis by blocking TGFβ-Smad3 and JNK-Smad3 pathways
6/26/2017 10:23:06 AM | Browse: 533 | Download: 553
48
Cardiac damage in athlete’s heart: When the “supernormal” heart fails!
6/26/2017 12:49:43 AM | Browse: 506 | Download: 336
49
Anti-steatotic and anti-fibrotic effects of the KCa3.1 channel inhibitor, Senicapoc, in non-alcoholic liver disease
6/20/2017 12:12:52 PM | Browse: 541 | Download: 762
50
Serelaxin increases the antifibrotic action of rosiglitazone in a model of hepatic fibrosis
6/14/2017 9:25:57 AM | Browse: 507 | Download: 515